Results 51 to 60 of about 3,980 (127)

Real‐World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background In the absence of randomized trials, selecting second or later‐line therapies in advanced sarcoma generally hinges on histology, patient performance status, and toxicity profile. We herein report a real‐world sarcoma referral center experience on continuous infusion Ifosfamide (ciIFO), in advanced Soft tissue sarcomas (STS) and bone
Ilaria Mascagni, Alice Laffi, Maria Susanna Grimaudo, Ferdinando Carlo Maria Cananzi, Laura Samà, Salvatore Lorenzo Renne, Federico D’Orazio, Pierina Navarria, Elena Clerici, Carlo Carnaghi, Sara Farinatti, Erika Stucchi, Marialudovica Le Moli, Laura Giordano, Robert G. Maki, Armando Santoro, Alexia Francesca Bertuzzi   +16 more
wiley   +1 more source

Giant Retroperitoneal Liposarcoma: A Case Report

Case Reports in Oncological Medicine, 2012
Soft tissue sarcomas represent less than 1% of all human neoplasms. One-third of malignant tumors that arise in the retroperitoneum are sarcomas and liposarcoma is the most common retroperitoneal sarcoma.
Chavan Shahaji, Parasnis Amit, Punia Prashant, Tekade Sachin   +3 more
doaj   +1 more source

Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas with a 5‐year survival rate of approximately 50%, secondary to their metastatic potential and resistance to therapy. MPNSTs can arise sporadically, as a late toxicity from therapeutic radiotherapy, or in patients with neurofibromatosis type 1 (NF1).
Rachel E. Aubrey, Pamela Psarianos, Anna T. Santiago, Anthony M. Griffin, Peter C. Ferguson, Abha A. Gupta, Hagit Peretz Soroka, David B. Shultz   +7 more
wiley   +1 more source

Radiogenomics: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang, Qingpei Lai, Jin Cao, Jerry Chi Fung Ching, Xinzhi Teng, Jiang Zhang, Shara Wee Yee Lee, Ge Ren, Jing Cai   +8 more
wiley   +1 more source

Retroperitoneal Dedifferentiated Liposarcoma With Penetrating Abscess Formation Secondary to Ileal Invasion: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Liposarcoma is a relatively common malignant soft tissue tumor in adults. Dedifferentiated liposarcoma (DLS) is a particularly invasive subtype characterized by high recurrence rates and a poor prognosis. We describe a case of a retroperitoneal liposarcoma with poor differentiation that presented with peritonitis accompanied by ileal ...
Kenichiro Yambe, Kei Nakagawa, Kuniharu Yamamoto, Hiroto Sakurai, Kazuhiro Takami, Noriko Kondo, Chikashi Shibata, Yu Katayose   +7 more
wiley   +1 more source

Sarcoma retroperitoneal gigante. Reporte de un caso clínico.

Cirugía del Uruguay, 2019
El liposarcoma es un tumor mesenquimático maligno, originado en el tejido adiposo, y constituye la variedad más frecuente de los sarcomas de ubicación retroperitoneal. Tienen un crecimiento lento con síntomas tardíos fundamentalmente dados por compresión,
Martín Varela Vega, Susana Reyes, José Cabillón, Daniel Czarnevicz, Fernando Simonet   +4 more
doaj   +1 more source

Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors

Zhongliu Fangzhi Yanjiu, 2019
Objective To investigate the relationship between neutrophils to lymphocytes ratio (NLR) and the prognosis of retroperitoneal liposarcoma patients and other prognostic factors.
FU Yali, MEI Shiwen, WEI Xing, LUO Chenghua, LIN Li, LIANG Jun   +5 more
doaj   +1 more source

RENAL REPLANTATION AT EXTENDED AND COMBINED RESECTION OF RETROPERITONEAL LIPOSARCOMA (CASE REPORT)

Acta Biomedica Scientifica, 2017
Non-organ retroperitoneal liposarcoma is the most frequent initial malignant tumor in retroperitoneal space and it comprises 40 % of all non-organ retroperitoneal tumors.
R. I. Rasulov, A. A. Muratov, V. V. Dvornichenko, D. D. Morikov, T. P. Teterina   +4 more
doaj   +1 more source

Liposarcoma retroperitoneal gigante. Reporte de caso (Giant retroperitoneal liposarcoma. Case report)

Avances en Biomedicina, 2015
Soft tissue sarcomas represent less than 1% of all human neoplasms. One-third of malignant tumors that arise in the retroperitoneum are sarcomas and liposarcoma is the most common retroperitoneal sarcoma and is known to grow to giant sizes, slow progress
Eduardo Reyna-Villasmil, Ismael Suárez-Torres, José Prieto-Montaño, María Labarca-Acosta   +3 more
doaj  

Retroperitoneal dedifferentiated liposarcoma with rare heterologous low-grade osteosarcoma: A case report

Radiology Case Reports
Dedifferentiated liposarcoma is a high-grade entity developed from a preexisting or recurrent well-differentiated liposarcoma, and rarely, it may contain divergent differentiation.
Chin-Yu Chiu, MD, Tzu-Ping Lin, MD, PhD, Jen-Fan Hang, MD, FIAC, Hsuen-En Huang, MD, Tzu-Hang Kao, MD, Shu-Huei Shen, MD   +5 more
doaj   +1 more source